SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?

Seeking Alpha05:12

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More

Benzinga03:51

CCORF Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,152

Futu NewsDec 21 02:31 · Ratings

Jefferies Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,200

Futu NewsDec 21 02:31 · Ratings

TD Cowen Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,230

Futu NewsDec 21 02:31 · Ratings

BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $950 From $1,190, Keeps Outperform Rating

MT NewswiresDec 20 23:24 · Ratings